In a report released today, Chris Schott from J.P. Morgan maintained a Hold rating on Pfizer (PFE – Research Report), with a price target of $57.00. The company’s shares closed last Tuesday at $50.34.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
According to TipRanks.com, Schott is a 1-star analyst with an average return of -0.1% and a 49.0% success rate. Schott covers the Healthcare sector, focusing on stocks such as Horizon Therapeutics, Coherus Biosciences, and Perrigo Company.
Pfizer has an analyst consensus of Moderate Buy, with a price target consensus of $60.88, a 20.2% upside from current levels. In a report issued on January 25, Mizuho Securities also maintained a Hold rating on the stock with a $56.00 price target.
See today’s best-performing stocks on TipRanks >>
The company has a one-year high of $61.71 and a one-year low of $33.36. Currently, Pfizer has an average volume of 39.91M.
Based on the recent corporate insider activity of 45 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of PFE in relation to earlier this year. Most recently, in December 2021, Mikael Dolsten, the President R&D of PFE bought 177,304 shares for a total of $4,588,404.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Pfizer Inc. develops, manufactures and sells healthcare products, including innovative medicines and vaccines. Its key focus areas include oncology, inflammation & immunology, rare disease, vaccines and internal medicine. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Read More on PFE: